Tandem Diabetes Care (TNDM) Research & Development (2013 - 2026)
Tandem Diabetes Care posted quarterly Research & Development of $46.0 million for Q1 2026, down 8.32% year-on-year from $50.2 million in Q1 2025, and little changed on a QoQ basis from $46.1 million in Q4 2025.
Tandem Diabetes Care (TNDM) has 14 years of Research & Development data on file, last reported at $46.0 million in Q1 2026.
- For the quarter ending Q1 2026, Research & Development fell 8.32% year-over-year to $46.0 million; the trailing twelve-month figure through Mar 2026 stood at $188.9 million (down 6.86% YoY), and the FY2025 full-year result was $193.1 million, down 2.9% from the prior year.
- Research & Development for Q1 2026 stood at $46.0 million, roughly flat from $46.1 million in the prior quarter.
- Across five years, Research & Development topped out at $52.2 million in Q4 2024 and bottomed at $33.2 million in Q1 2022.
- The 5-year median for Research & Development is $46.0 million (2026), against an average of $43.9 million.
- The widest annual swing landed in 2022, when Research & Development jumped 84.62%; it then fell 11.75% in 2025.
- A 5-year view of Research & Development shows it stood at $35.6 million in 2022, then rose by 19.72% to $42.6 million in 2023, then grew by 22.52% to $52.2 million in 2024, then dropped by 11.75% to $46.1 million in 2025, then dropped by 0.07% to $46.0 million in 2026.
- The last three Research & Development figures came in at $46.0 million (Q1 2026), $46.1 million (Q4 2025), and $48.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Tandem Diabetes Care | 1.31 Bn | 739.55 Mn | 136.79 Mn | 46.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.04 Mn |
| Dec 31, 2025 | 46.07 Mn |
| Sep 30, 2025 | 48.72 Mn |
| Jun 30, 2025 | 48.12 Mn |
| Mar 31, 2025 | 50.22 Mn |
| Dec 31, 2024 | 52.20 Mn |
| Sep 30, 2024 | 51.11 Mn |
| Jun 30, 2024 | 49.33 Mn |
| Mar 31, 2024 | 46.24 Mn |
| Dec 31, 2023 | 42.60 Mn |
| Sep 30, 2023 | 41.97 Mn |
| Jun 30, 2023 | 42.93 Mn |
| Mar 31, 2023 | 42.16 Mn |
| Dec 31, 2022 | 35.59 Mn |
| Sep 30, 2022 | 36.80 Mn |
| Jun 30, 2022 | 33.57 Mn |
| Mar 31, 2022 | 33.16 Mn |
| Dec 31, 2021 | 29.49 Mn |
| Sep 30, 2021 | 24.10 Mn |
| Jun 30, 2021 | 20.50 Mn |
| Mar 31, 2021 | 17.96 Mn |
| Dec 31, 2020 | 17.38 Mn |
| Sep 30, 2020 | 16.09 Mn |
| Jun 30, 2020 | 15.99 Mn |
| Mar 31, 2020 | 14.12 Mn |
| Dec 31, 2019 | 12.57 Mn |
| Sep 30, 2019 | 12.04 Mn |
| Jun 30, 2019 | 11.20 Mn |
| Mar 31, 2019 | 9.39 Mn |
| Dec 31, 2018 | 8.80 Mn |
| Sep 30, 2018 | 8.00 Mn |
| Jun 30, 2018 | 6.46 Mn |
| Mar 31, 2018 | 5.98 Mn |
| Dec 31, 2017 | 5.75 Mn |
| Sep 30, 2017 | 4.91 Mn |
| Jun 30, 2017 | 4.87 Mn |
| Mar 31, 2017 | 5.13 Mn |
| Dec 31, 2016 | 4.35 Mn |
| Sep 30, 2016 | 6.15 Mn |
| Jun 30, 2016 | 4.14 Mn |
| Mar 31, 2016 | 4.17 Mn |
| Dec 31, 2015 | 4.14 Mn |
| Sep 30, 2015 | 5.09 Mn |
| Jun 30, 2015 | 3.87 Mn |
| Mar 31, 2015 | 3.86 Mn |
| Dec 31, 2014 | 3.92 Mn |
| Sep 30, 2014 | 4.51 Mn |
| Jun 30, 2014 | 3.70 Mn |
| Mar 31, 2014 | 3.66 Mn |
| Dec 31, 2013 | 3.35 Mn |
| Sep 30, 2013 | 2.65 Mn |
| Jun 30, 2013 | 2.76 Mn |
| Mar 31, 2013 | 2.32 Mn |